Albion Financial Group Boston Scientific Corp Transaction History
Albion Financial Group
- $1.48 Billion
- Q2 2025
A detailed history of Albion Financial Group transactions in Boston Scientific Corp stock. As of the latest transaction made, Albion Financial Group holds 662 shares of BSX stock, worth $70,675. This represents 0.0% of its overall portfolio holdings.
Number of Shares
662
Previous 662
-0.0%
Holding current value
$70,675
Previous $66,000
7.58%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BSX
# of Institutions
1,869Shares Held
1.22BCall Options Held
9.9MPut Options Held
7.3M-
Vanguard Group Inc Valley Forge, PA135MShares$14.4 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$13.5 Billion0.22% of portfolio
-
State Street Corp Boston, MA64.5MShares$6.88 Billion0.28% of portfolio
-
Primecap Management CO Pasadena, CA36.5MShares$3.9 Billion3.11% of portfolio
-
Wellington Management Group LLP Boston, MA33.2MShares$3.54 Billion0.67% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $153B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...